Hutch News

Hutch News

Stories tagged 'Lawrence Corey'

Dr. Sue Biggins elected to American Academy of Arts & Sciences

Biologist is ninth Hutch researcher to join one of the nation's oldest learned societies

April 18, 2018 | By Rachel Tompa / Fred Hutch News Service

The American Academy of Arts & Sciences has announced its 238th class of new members, including Fred Hutch biologist Dr. Sue Biggins.

View story >


With approval of new CMV drug for transplant patients, a legacy continues

Tissue samples from a clinical trial conducted decades ago yield new insights and treatments

April 12, 2018 | By Mary Engel / Fred Hutch News Service

Tissue samples from a landmark clinical trial conducted decades ago by the late Dr. Joel Meyers yield new insights and treatments

View story >


When scientific hypotheses don’t pan out

Research studies are often built around an educated guess. What happens when those guesses are wrong?

Feb. 16, 2018 | By Rachel Tompa / Fred Hutch News Service

Researchers are always prepared for the possibility of a disproven hypothesis. But what happens when a beloved idea or dogma is shattered is less technical, less predictable. More human.

View story >


Meet Peru's HIV superhero

By finding a better way to prevent HIV, Dr. Jorge Sanchez aims to help end his country’s AIDS epidemic

Jan. 22, 2018 | By Mary Engel / Fred Hutch News Service

A leader in Peru's battle against HIV/AIDS, Dr. Jorge Sanchez's superpower is research. He is working with the Fred Hutch-based HIV Vaccine Trials Network on a potentially landmark prevention study.

View story >


10 highlights of Fred Hutch science in 2017

A look back at notable discoveries in cancer immunotherapy, HIV prevention and more

Dec. 28, 2017 | by Sabin Russell and Susan Keown / Fred Hutch News Service

It's been a year of breakthroughs at Fred Hutch. Here are 10 of our favorites.

View story >


New 'mosaic' HIV vaccine study launched for World AIDS Day

As lights around the world glow red today, Fred Hutch-based researchers lead global effort to end the pandemic

Dec. 1, 2017 | By Mary Engel / Fred Hutch News Service

The HIV Vaccine Trials Network is having a banner year. Last month in South Africa, the network launched a clinical trial called the Imbokodo Study to test an experimental vaccine regimen designed to protect against HIV subtypes around the world. Over the coming months, the Imbokodo study will roll out in four other southern African countries.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.